Diatreme Resources Limited Price Chart
Diatreme Resources Limited DRX.XA Financial and Trading Overview
| Diatreme Resources Limited stock price | 0.02 AUD |
| Previous Close | 0.03 AUD |
| Open | 0.03 AUD |
| Bid | 0.02 AUD x N/A |
| Ask | 0.03 AUD x N/A |
| Day's Range | 0.03 - 0.03 AUD |
| 52 Week Range | 0.02 - 0.05 AUD |
| Volume | 873.5K AUD |
| Avg. Volume | 646.06K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.830651 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.001 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
DRX.XA Valuation Measures
| Enterprise Value | 77.41M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.7857143 |
| Enterprise Value/Revenue | 702.893 |
| Enterprise Value/EBITDA | -25.22 |
Trading Information
Diatreme Resources Limited Stock Price History
| Beta (5Y Monthly) | 0.830651 |
| 52-Week Change | -12.90% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.05 AUD |
| 52 Week Low | 0.02 AUD |
| 50-Day Moving Average | 0.03 AUD |
| 200-Day Moving Average | 0.03 AUD |
DRX.XA Share Statistics
| Avg. Volume (3 month) | 646.06K AUD |
| Avg. Daily Volume (10-Days) | 329.85K AUD |
| Shares Outstanding | N/A |
| Float | 1.05B |
| Short Ratio | N/A |
| % Held by Insiders | 70.22% |
| % Held by Institutions | 0.18% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 4520.16% |
| Operating Margin (ttm) | -2889.60% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -4.49% |
| Return on Equity (ttm) | 11.92% |
Income Statement
| Revenue (ttm) | 110.14K AUD |
| Revenue Per Share (ttm) | 0 AUD |
| Quarterly Revenue Growth (yoy) | 16856.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -3069593 AUD |
| Net Income Avi to Common (ttm) | 4.98M AUD |
| Diluted EPS (ttm) | -0.001 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.64M AUD |
| Total Cash Per Share (mrq) | 0.004 AUD |
| Total Debt (mrq) | 1.54M AUD |
| Total Debt/Equity (mrq) | 2.92 AUD |
| Current Ratio (mrq) | 14.09 |
| Book Value Per Share (mrq) | 0.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2508164 AUD |
| Levered Free Cash Flow (ttm) | -8762700 AUD |
Profile of Diatreme Resources Limited
| Country | Australia |
| State | QLD |
| City | Coorparoo |
| Address | 55-61 Holdsworth Street |
| ZIP | 4151 |
| Phone | 61 7 3397 2222 |
| Website | https://www.diatreme.com.au |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Diatreme Resources Limited engages in the exploration of heavy mineral sands, copper, gold, and base metals in Australia. Its flagship property is the Galalar Silica Sand project located in North Queensland. The company was incorporated in 1993 and is based in Coorparoo, Australia.
Q&A For Diatreme Resources Limited Stock
What is a current DRX.XA stock price?
Diatreme Resources Limited DRX.XA stock price today per share is 0.02 AUD.
How to purchase Diatreme Resources Limited stock?
You can buy DRX.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Diatreme Resources Limited?
The stock symbol or ticker of Diatreme Resources Limited is DRX.XA.
How many shares does Diatreme Resources Limited have in circulation?
The max supply of Diatreme Resources Limited shares is 0.
What is Diatreme Resources Limited Price to Earnings Ratio (PE Ratio)?
Diatreme Resources Limited PE Ratio is now.
What was Diatreme Resources Limited earnings per share over the trailing 12 months (TTM)?
Diatreme Resources Limited EPS is -0.001 AUD over the trailing 12 months.